Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Human peripheral monocytes are key immune cells involved in inflammatory responses.
• Prostaglandins and thromboxanes are critical eicosanoids mediating inflammation and immune cell function.

Purpose of the Study:

• To investigate the short-term effects of interleukin 1 (IL-1), lipopolysaccharide (LPS), and interferons (IFNs) on prostaglandin release from human monocytes.
• To elucidate the regulatory roles of IL-1 and IFNs in monocyte eicosanoid production.

Main Methods:

• Freshly isolated human peripheral monocytes were pretreated with IL-1, LPS, IFN-alpha, or IFN-gamma.
• Prostaglandin and thromboxane release were measured following pretreatment.
• Inhibition kinetics and effective concentrations of interferons were determined.

Main Results:

• Pretreatment with E. coli lipopolysaccharide or recombinant interleukin 1 (beta) significantly increased prostaglandin release from monocytes.
• Inclusion of recombinant IFN-alpha or IFN-gamma during pretreatment blocked subsequent prostaglandin release.
• Interferon-mediated inhibition occurred within hours at concentrations of 1-10 antiviral units/ml, with similar effects observed for thromboxane release.

Conclusions:

• Interleukin 1 and lipopolysaccharide act as stimulators of eicosanoid release from human monocytes.
• Interferons (IFN-alpha and IFN-gamma) exhibit antagonistic effects, inhibiting IL-1 and LPS-induced prostaglandin and thromboxane release.
• These data suggest complex, opposing regulatory roles for IL-1 and IFNs in monocyte eicosanoid metabolism during inflammatory processes.